RESEARCH TRIANGLE PARK, N.C., June 14 /PRNewswire/ -- Max Neeman International, India's premier CRO, has entered into the cosmetics arena as this industry recognizes the Indian market potential due to favorable changes in the country's demographics. A dedicated and experienced Max Neeman team has been set-up to conduct cosmetic studies for evaluation and efficacy of products. Team members include specialized dermatologists with years of working experience in the respective fields.
The Cosmetic industry in India has witnessed rapid growth in the past five years, due to improved purchasing power and higher fashion consciousness. Indian herbal cosmetic products have also seen increased demand in the international market. According to a report on the Indian Cosmetic Industry Analysis the industry is projected to grow at a CAGR of 7% during the period 2010 – 2012.
The demographics of India are remarkably diverse. India is the second-largest populated country in the world with over 1.18 billion people (estimate for April, 2010) and consists of more than one-sixth of the world's population. It contributes 17.31% of the world's population and is projected that India will be the largest populated country by 2025 surpassing China, and by 2050 it will have over 1.6 billion people.
Max Neeman International conducts studies to evaluate cosmetic products from a dermatologic perspective, providing crucial information for product approval and consumer satisfaction.
About Max Neeman International
Max Neeman International is one of the leading and largest CROs in India. Our specialty is that we offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 6 regional offices. Contact Donald Swankie, Vice President of Business Development via email to firstname.lastname@example.org or call +1.919.424.3345. For more information please visit www.neeman-medical.com.
SOURCE Max Neeman International